NCT03298945View on ClinicalTrials.gov

Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens

PHASE4CompletedINTERVENTIONAL
Enrollment

2,239

Participants

Timeline

Start Date

December 13, 2018

Primary Completion Date

December 30, 2023

Study Completion Date

June 30, 2024

Conditions
Colorectal Cancer
Interventions
DRUG

Miralax-Gatorade Prep

2-L split-dose Miralax-Gatorade bowel prep for colonoscopy

DRUG

Golytely

4-L split dose Golytely is the current standard prep at the VA

Trial Locations (1)

19104-4551

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT03298945 - Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens | Biotech Hunter | Biotech Hunter